{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:38:30Z","timestamp":1648611510274},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1992,3,1]],"date-time":"1992-03-01T00:00:00Z","timestamp":699408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Virology"],"published-print":{"date-parts":[[1992,3]]},"DOI":"10.1007\/bf01314632","type":"journal-article","created":{"date-parts":[[2005,3,26]],"date-time":"2005-03-26T05:33:35Z","timestamp":1111815215000},"page":"147-155","source":"Crossref","is-referenced-by-count":0,"title":["Relation between drug resistance and antigenicity among norakin-resistant mutants of influenza A (fowl plague) virus"],"prefix":"10.1007","volume":"124","author":[{"given":"A. I.","family":"Klimov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Markushin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pr\ufffdsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. P.","family":"Ginzburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Heider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Heider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schr\ufffdeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. G.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0042-6822(79)90358-1","volume":"97","author":"GM Air","year":"1979","unstructured":"Air GM (1979) Nucleotide sequence coding for the ?signal peptide? and N terminus of the haemagglutinin from an asian (H2N2) strain of influenza virus. Virology 97: 468?472","journal-title":"Virology"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1099\/0022-1317-36-2-249","volume":"36","author":"G Appleyard","year":"1977","unstructured":"Appleyard G (1977) Amantadine-resistance as a genetic marker for influenza viruses. J Gen Virol 36: 249?255","journal-title":"J Gen Virol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/infdis\/159.6.1050","volume":"159","author":"WJ Bean","year":"1989","unstructured":"Bean WJ, Threlkeld SC, Webster RG (1989) Biological potential of amantadine-resistant influenza A virus in an avian model. J Infect Dis 159: 1050?1056","journal-title":"J Infect Dis"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/JVI.62.5.1508-1512.1988","volume":"62","author":"RB Belshe","year":"1988","unstructured":"Belshe RB, Hall-Smith MH, Hall CB, Betts R, Hay AJ (1988) Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol 62: 1508?1512","journal-title":"J Virol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/infdis\/159.3.430","volume":"159","author":"RB Belshe","year":"1989","unstructured":"Belshe RB, Burk B, Newman F, Cerruti RL, Sim IS (1989) Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 159: 430?435","journal-title":"J Infect Dis"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01311008","volume":"114","author":"LE Brown","year":"1990","unstructured":"Brown LE, Murray JM, White DO, Jackson DC (1990) An analysis of the properties of monoclonal antibodies directed to epitopes of influenza virus haemagglutinin. Arch Virol 114: 1?26","journal-title":"Arch Virol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(85)90157-6","volume":"40","author":"RS Daniels","year":"1985","unstructured":"Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, Wiley DC (1985) Fusion mutants of the influenza virus haemagglutinin glycoprotein. Cell 40: 431?439","journal-title":"Cell"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1099\/0022-1317-67-6-1115","volume":"67","author":"Y Ghendon","year":"1986","unstructured":"Ghendon Y, Markushin S, Heider H, Melnikov S, Lotte V (1986) Haemagglutinin of influenza A virus is a target for antiviral effect of Norakin. J Gen Virol 67: 1115?1122","journal-title":"J Gen Virol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","volume":"4","author":"AJ Hay","year":"1985","unstructured":"Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH (1985) The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4: 3021?3024","journal-title":"EMBO J"},{"issue":"Suppl B","key":"CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/18.Supplement_B.19","volume":"18","author":"AJ Hay","year":"1986","unstructured":"Hay AJ, Zambon MC, Wolstenholme AJ, Skehel JJ, Smith MH (1986) Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemotherapy 18 [Suppl B]: 19?29","journal-title":"J Antimicrob Chemotherapy"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJM198912213212502","volume":"321","author":"FG Hayden","year":"1989","unstructured":"Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W (1989) Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 321: 1696?1702","journal-title":"N Engl J Med"},{"key":"CR12","first-page":"395","volume":"25","author":"H Heider","year":"1981","unstructured":"Heider H, Adamczyk B, Presber HW, Schr\u00f6eder C, Feldblum R, Indulen MK (1981) Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic. Acta Virol (Praha) 25: 395?400","journal-title":"Acta Virol (Praha)"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF01309832","volume":"86","author":"H Heider","year":"1985","unstructured":"Heider H, Markushin S, Schr\u00f6eder C, Ghendon Y (1985) The influence of Norakin on the reproduction of influenza A and B viruses. Arch Virol 86: 283?290","journal-title":"Arch Virol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0042-6822(82)90375-0","volume":"122","author":"H Kida","year":"1982","unstructured":"Kida H, Brown RE, Webster RG (1982) Biological activity of monoclonal antibodies to operationally defined antigenic regions of the haemagglutinin molecule of A\/seal\/Massachusetts\/1\/80 (H7N7) influenza virus. Virology 122: 38?47","journal-title":"Virology"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01321124","volume":"122","author":"AI Klimov","year":"1992","unstructured":"Klimov AI, Pr\u00f6sch S, Sch\u00e4fer J (1992) Subtype H7N7 influenza viruses: comparative antigenic and molecular analysis of the HA-, M-, and NS-genes. Arch Virol 122: 143?161","journal-title":"Arch Virol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/226082a0","volume":"226","author":"JS Oxford","year":"1970","unstructured":"Oxford JS, Logan IS, Potter CW (1970) In vivo selection of an influenza A 2 strain resistant to amantadine. Nature 226: 82?83","journal-title":"Nature"},{"issue":"Suppl B","key":"CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/18.Supplement_B.135","volume":"18","author":"RM Pemberton","year":"1986","unstructured":"Pemberton RM, Jennings R, Porter CW, Oxford JS (1986) Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates. J Antimicrob Chemother 18 [Suppl B]: 135?140","journal-title":"J Antimicrob Chemother"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01315569","volume":"102","author":"S Pr\u00f6sch","year":"1988","unstructured":"Pr\u00f6sch S, Heider H, Schr\u00f6eder C, Kr\u00fcger DH (1988) Mutations in the haemagglutinin gene associated with influenza virus resistance to norakin. Arch Virol 102: 125?129","journal-title":"Arch Virol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-5793(90)80277-P","volume":"267","author":"S Pr\u00f6sch","year":"1990","unstructured":"Pr\u00f6sch S, Heider H, Schr\u00f6eder C, Shilov AA, Sinitzyn BV, Blinov BM, Kr\u00fcger DH, Frommel C (1990) Mapping mutations in influenza A virus resistant to norakin. FEBS Lett 267: 19?21","journal-title":"FEBS Lett"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","volume":"74","author":"F Sanger","year":"1977","unstructured":"Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463?5467","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl","key":"CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0166-3542(85)80014-0","volume":"1","author":"C Schr\u00f6eder","year":"1985","unstructured":"Schr\u00f6eder C, Heider H, Hegenscheid B, Sch\u00f6ffel M, Bubovich VI, Rosenthal HA (1985) The anticholinergic anti-Parkinson drug Norakin selectively inhibits influenza virus replication. Antiviral Res [Suppl] 1: 95?99","journal-title":"Antiviral Res"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1073\/pnas.79.4.968","volume":"79","author":"JJ Skehel","year":"1982","unstructured":"Skehel JJ, Bayley PM, Brown EB, Martin SR, Waterfield MD, White JM, Wilson IA, Wiley DC (1982) Changes in the conformation of influenza virus haemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci USA 79: 968?972","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/JVI.55.1.173-176.1985","volume":"55","author":"RG Webster","year":"1985","unstructured":"Webster RG, Kawaoka Y, Bean WJ, Beard CW, Brugh M (1985) Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus. J Virol 55: 173?176","journal-title":"J Virol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.bi.56.070187.002053","volume":"56","author":"DC Wiley","year":"1987","unstructured":"Wiley DC, Skehel JJ (1987) The structure and function of the haemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56: 365?394","journal-title":"Annu Rev Biochem"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01314632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01314632\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01314632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T14:30:01Z","timestamp":1586183401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01314632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["BF01314632"],"URL":"https:\/\/doi.org\/10.1007\/bf01314632","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}